Showing results (51-60 of 76) with videos related to
Sort By:
Pageof 8
Biological & Pharmaceutical Bulletin|May 1, 2024
Inhibition Mechanism of SARS-CoV-2 Infection by a Cholesterol Derivative, Nat-20(S)-yneMana Murae, Shota Sakai, Non Miyata, et al.Msphere|July 14, 2021
Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012Atsushi Yamanaka, Mami Matsuda, Tamaki Okabayashi, et al.The Journal of Pharmacology and Experimental Therapeutics|September 21, 2017
Creation of a Claudin-2 Binder and Its Tight Junction-Modulating Activity in a Human Intestinal ModelMutsumi Takigawa, Manami Iida, Shotaro Nagase, et al.The Journal of Pharmacology and Experimental Therapeutics|July 4, 2015
Claudin-1 Binder Enhances Epidermal Permeability in a Human Keratinocyte ModelMisaki Nakajima, Shotaro Nagase, Manami Iida, et al.Journal of Virology|February 13, 2015
Monoclonal antibodies against extracellular domains of claudin-1 block hepatitis C virus infection in a mouse modelMasayoshi Fukasawa, Shotaro Nagase, Yoshitaka Shirasago, et al.Biochemical and Biophysical Research Communications|December 18, 2013
Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCPMasashi Iwamoto, Koichi Watashi, Senko Tsukuda, et al.Biochemical and Biophysical Research Communications|May 14, 2019
Human-rat chimeric anti-occludin monoclonal antibodies inhibit hepatitis C virus infectionYoshimi Shimizu, Kohei Yoneda, Yoshitaka Shirasago, et al.FEBS Letters|October 28, 2020
Occludin-binding single-chain variable fragment and antigen-binding fragment antibodies prevent hepatitis C virus infectionYoshimi Shimizu, Takehiro Shinoda, Yoshitaka Shirasago, et al.Molecular Biology of the Cell|January 27, 2004
Countercurrent distribution of two distinct SNARE complexes mediating transport within the Golgi stackAllen Volchuk, Mariella Ravazzola, Alain Perrelet, et al.The Journal of Biological Chemistry|November 2, 2018
The aryl hydrocarbon receptor-cytochrome P450 1A1 pathway controls lipid accumulation and enhances the permissiveness for hepatitis C virus assemblyHirofumi Ohashi, Kazane Nishioka, Syo Nakajima, et al.Pageof 8